CN103476273A - 应用于胃肠疾病的两歧双歧杆菌菌株 - Google Patents

应用于胃肠疾病的两歧双歧杆菌菌株 Download PDF

Info

Publication number
CN103476273A
CN103476273A CN2012800125218A CN201280012521A CN103476273A CN 103476273 A CN103476273 A CN 103476273A CN 2012800125218 A CN2012800125218 A CN 2012800125218A CN 201280012521 A CN201280012521 A CN 201280012521A CN 103476273 A CN103476273 A CN 103476273A
Authority
CN
China
Prior art keywords
strain
probiotic
variant
mutant
bifidobacterium bifidum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012800125218A
Other languages
English (en)
Chinese (zh)
Inventor
S·古列尔梅蒂
D·莫拉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Naturwohl Pharma GmbH
Original Assignee
Naturwohl Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naturwohl Pharma GmbH filed Critical Naturwohl Pharma GmbH
Publication of CN103476273A publication Critical patent/CN103476273A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN2012800125218A 2011-01-31 2012-01-27 应用于胃肠疾病的两歧双歧杆菌菌株 Pending CN103476273A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11000744.0A EP2481299B1 (en) 2011-01-31 2011-01-31 Bifidobacterium bifidum strains for application in gastrointestinal diseases
EP11000744.0 2011-01-31
PCT/EP2012/051369 WO2012104226A1 (en) 2011-01-31 2012-01-27 Bifidobacterium bifidum strains for application in gastrointestinal diseases

Publications (1)

Publication Number Publication Date
CN103476273A true CN103476273A (zh) 2013-12-25

Family

ID=43901563

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012800125218A Pending CN103476273A (zh) 2011-01-31 2012-01-27 应用于胃肠疾病的两歧双歧杆菌菌株

Country Status (15)

Country Link
US (1) US9408879B2 (https=)
EP (1) EP2481299B1 (https=)
JP (1) JP5956467B2 (https=)
CN (1) CN103476273A (https=)
AU (1) AU2012213576B2 (https=)
BR (1) BR112013019258B1 (https=)
CA (1) CA2825980C (https=)
DK (1) DK2481299T3 (https=)
ES (1) ES2610908T3 (https=)
HR (1) HRP20161792T1 (https=)
HU (1) HUE033189T2 (https=)
PL (1) PL2481299T3 (https=)
PT (1) PT2481299T (https=)
RU (1) RU2603285C2 (https=)
WO (1) WO2012104226A1 (https=)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104546945A (zh) * 2014-09-30 2015-04-29 深圳华大基因科技有限公司 两歧双歧杆菌在治疗或预防类风湿性关节炎或其相关疾病中的用途
CN106579414A (zh) * 2016-12-26 2017-04-26 北京康比特体育科技股份有限公司 一种缓解运动性腹泻的组合物
CN106834187A (zh) * 2017-03-06 2017-06-13 江南大学 一种两歧双歧杆菌及其用途
CN107567333A (zh) * 2015-03-09 2018-01-09 生物免疫Sagl公司 包含抗氧化剂与双歧杆菌和从益生菌分离的细胞壁的抗衰老组合物
CN109069553A (zh) * 2016-04-14 2018-12-21 杜邦营养生物科学有限公司 用于增加瘦体重的双歧杆菌
CN111110704A (zh) * 2020-02-14 2020-05-08 上海城建职业学院 一种益生菌菌剂、滴剂及其制备方法和应用
CN111743998A (zh) * 2020-06-04 2020-10-09 中通美雅生命健康(深圳)有限公司 用于辅助治疗肠炎组合物及其制备方法
CN112074193A (zh) * 2018-01-29 2020-12-11 精密生物集团有限公司 一种用于预防和治疗肠易激综合征的组合产品
CN112312920A (zh) * 2018-06-22 2021-02-02 合成制剂有限公司 非存活两歧双歧杆菌及其用途
CN113234619A (zh) * 2021-04-10 2021-08-10 江南大学 一株两歧双歧杆菌及其在缓解肠道损伤中的应用
CN114127258A (zh) * 2019-07-08 2022-03-01 索法尔公司 两歧双歧杆菌细菌菌株、其组合物和相关应用
CN116286439A (zh) * 2022-07-13 2023-06-23 四川大学 一株婴幼儿肠道来源的两歧双歧杆菌及应用
WO2024193633A1 (zh) * 2023-03-21 2024-09-26 四川厌氧生物科技有限责任公司 一种益生菌及其应用
CN118879582A (zh) * 2024-09-19 2024-11-01 上海博诗康生物科技有限公司 一种细胞完整、分散均匀、稳定性强的后生元制备方法

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
CN103266076B (zh) * 2013-06-04 2014-10-29 神舟太空产品高科技成果推广中心集团有限公司 太空诱变高效两歧双歧杆菌、其应用及其胶囊制剂的制备方法
SG11201704814SA (en) 2014-12-23 2017-07-28 4D Pharma Res Ltd Pirin polypeptide and immune modulation
WO2016102950A1 (en) 2014-12-23 2016-06-30 4D Pharma Research Limited Immune modulation
WO2016203221A1 (en) 2015-06-15 2016-12-22 4D Pharma Research Limited Compositions comprising bacterial strains
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
ME03511B (me) 2015-06-15 2020-04-20 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
HRP20191949T1 (hr) 2015-06-15 2020-01-24 4D Pharma Research Limited Blautia stercosis i wexlerae za upotrebu u liječenju upalnih i autoimunih bolesti
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
JP6637725B2 (ja) * 2015-10-28 2020-01-29 ビオフェルミン製薬株式会社 ウイルス感染症の予防及び／又は治療剤
HK1254843B (zh) 2015-11-20 2020-04-17 希杰生物科技株式会社 包含细菌菌株的组合物
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
SG10201913557TA (en) 2016-03-04 2020-02-27 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
US20180256505A1 (en) * 2017-03-09 2018-09-13 The Clorox Company Probiotic capsule and methods of preparing the same
JP2018177703A (ja) * 2017-04-14 2018-11-15 株式会社明治 Ｔｏｌｌ様受容体２活性化用組成物
ES2877726T3 (es) 2017-05-22 2021-11-17 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
EP3630942B1 (en) 2017-05-24 2022-11-30 4D Pharma Research Limited Compositions comprising bacterial strain
TWI812624B (zh) 2017-06-14 2023-08-21 南韓商希杰生物科技股份有限公司 包含細菌品系之組成物
ES2841902T3 (es) 2017-06-14 2021-07-12 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
PL3600363T3 (pl) 2017-06-14 2021-06-14 4D Pharma Research Limited Kompozycje zawierające szczepy bakteryjne
KR102023700B1 (ko) * 2018-01-31 2019-09-20 주식회사 비피도 비피도박테리움을 함유한 류마티스관절염 개선용, 치료용 또는 예방용 조성물
CN112912088B (zh) * 2019-01-16 2024-12-24 N·V·努特里奇亚 用于轮状病毒引起的感染的具有非消化性寡糖的经发酵配方食品
BR112022004032A2 (pt) * 2019-09-05 2022-05-24 Superbrewed Food Inc Composições probióticas mixotróficas e usos das mesmas no tratamento de distensão abdominal
IT201900016811A1 (it) * 2019-09-20 2021-03-20 Sofar Spa Ceppi batterici, loro composizioni e loro uso per il trattamento di disturbi gastrointestinali
CN118924795A (zh) * 2019-11-29 2024-11-12 内蒙古伊利实业集团股份有限公司 乳双歧杆菌bl-99提升肠道细菌感染抗性和肠道免疫力的应用
RU2735717C1 (ru) * 2020-06-15 2020-11-06 Общество с ограниченной ответственностью "АВАН" Штамм Bifidobacterium bifidum, используемый в качестве пробиотика
JP2023542547A (ja) * 2020-09-23 2023-10-10 ピービーエルバイオラブ 新規乳酸菌およびその用途
CN113943682B (zh) * 2020-11-12 2023-07-04 江南大学 缓解便秘的长双歧杆菌长亚种及其制备的发酵食品与益生菌制剂
WO2022103638A1 (en) 2020-11-16 2022-05-19 Orcosa Inc. Cannabinoids in the treatment of autism spectrum disorder
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
CN112980734B (zh) * 2021-03-24 2022-07-22 江南大学 一株缓解便秘并调节肠道菌群紊乱的两歧双歧杆菌及其应用
CN113025526B (zh) * 2021-03-24 2022-09-27 江南大学 一株减少结肠病理损伤且具有缓解便秘作用的两歧双歧杆菌
CN116004416B (zh) * 2022-07-13 2024-05-10 四川大学 婴幼儿肠道来源的两歧双歧杆菌的应用
CN115838662A (zh) * 2022-11-02 2023-03-24 江南大学 一株具有缓解克罗恩病潜力的两歧双歧杆菌
CN118044616A (zh) * 2023-09-05 2024-05-17 厦门大学 一种合生元及其用途
WO2025059424A1 (en) * 2023-09-15 2025-03-20 Biohm Health Inc. Pro-biotic compositions and methods for treatment of stress
CN121102165A (zh) * 2025-11-13 2025-12-12 厦门承葛生物科技有限公司 用于精准肠道菌群移植的肠道菌群胶囊及其制备方法和应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1891236A (zh) * 2005-07-05 2007-01-10 广州市微生物研究所 多联活性双歧杆菌产品的制备方法
CN101039687A (zh) * 2004-08-05 2007-09-19 安尼德拉尔有限公司 产生叶酸的双岐杆菌菌株，及其制剂和应用
CN101228262A (zh) * 2005-07-21 2008-07-23 株式会社益力多本社 新型双歧杆菌属细菌及其利用
CN101636173A (zh) * 2007-03-27 2010-01-27 宝洁公司 施用益生菌剂的方法及试剂盒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29150A (id) 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
RU2152993C1 (ru) * 1999-11-30 2000-07-20 Государственный научный центр РФ Институт медико-биологических проблем Штамм bifidobacterium bifidum вкпм ас-1578, используемый для приготовления бактериальных препаратов и продуктов питания
RU2184146C1 (ru) * 2001-01-29 2002-06-27 Закрытое акционерное общество "Партнер" Штамм bifidobacterium bifidum 45 вкпм ас-1621, используемый для приготовления бактериальных препаратов и продуктов питания
ATE360682T1 (de) * 2003-06-30 2007-05-15 Clasado Inc Neue galactooligosaccharidzusammensetzung und herstellung davon
AU2006253007B2 (en) * 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
US9084434B2 (en) * 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
EP2270133B1 (en) * 2008-04-22 2015-06-24 Corporación Alimentaria Peñasanta (Capsa) Method for obtaining a novel strain of bifidobacterium bifidum with activity against infection by helicobacter pylori
EP2280713A1 (en) * 2008-05-01 2011-02-09 The Procter & Gamble Company Methods and kits for the treatment of inflammatory bowel disorder conditions
ES2656776T3 (es) * 2008-06-13 2018-02-28 N.V. Nutricia Composición nutricional para bebés nacidos por cesárea

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101039687A (zh) * 2004-08-05 2007-09-19 安尼德拉尔有限公司 产生叶酸的双岐杆菌菌株，及其制剂和应用
CN1891236A (zh) * 2005-07-05 2007-01-10 广州市微生物研究所 多联活性双歧杆菌产品的制备方法
CN101228262A (zh) * 2005-07-21 2008-07-23 株式会社益力多本社 新型双歧杆菌属细菌及其利用
CN101636173A (zh) * 2007-03-27 2010-01-27 宝洁公司 施用益生菌剂的方法及试剂盒

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
SIMONE GUGLIELMETTI 等: "Implication of an Outer Surface Lipoprotein in Adhesion of Bifidobacterium bifidum to Caco-2 Cells", 《APPLIED AND ENVIRONMENTAL MICROBIOLOGY》, vol. 74, no. 15, 31 August 2008 (2008-08-31), XP 002634993, DOI: doi:10.1128/AEM.00124-08 *
SIMONE GUGLIELMETTI等: "Study of the Adhesion of Bifidobacterium MIMBb75 to Human Intestinal Cell Lines", 《CURR MICROBIOL》, 19 March 2009 (2009-03-19), pages 167 - 172, XP 002634994, DOI: doi:10.1007/S00284-009-9415-X *
崔岸: "《自然生物疗法-益生菌保健与使用指南》", 31 December 2006, article "益生菌与肠易激综合征和炎症性肠病", pages: 27-33 *
燕善军: "双歧杆菌对肠易激综合征的治疗价值", 《蚌埠医学院学报》 *

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104546945A (zh) * 2014-09-30 2015-04-29 深圳华大基因科技有限公司 两歧双歧杆菌在治疗或预防类风湿性关节炎或其相关疾病中的用途
CN107567333A (zh) * 2015-03-09 2018-01-09 生物免疫Sagl公司 包含抗氧化剂与双歧杆菌和从益生菌分离的细胞壁的抗衰老组合物
CN109069553A (zh) * 2016-04-14 2018-12-21 杜邦营养生物科学有限公司 用于增加瘦体重的双歧杆菌
CN106579414A (zh) * 2016-12-26 2017-04-26 北京康比特体育科技股份有限公司 一种缓解运动性腹泻的组合物
CN106834187B (zh) * 2017-03-06 2020-08-25 江南大学 一种两歧双歧杆菌及其用途
CN106834187A (zh) * 2017-03-06 2017-06-13 江南大学 一种两歧双歧杆菌及其用途
CN112074193A (zh) * 2018-01-29 2020-12-11 精密生物集团有限公司 一种用于预防和治疗肠易激综合征的组合产品
CN112312920A (zh) * 2018-06-22 2021-02-02 合成制剂有限公司 非存活两歧双歧杆菌及其用途
CN114127258A (zh) * 2019-07-08 2022-03-01 索法尔公司 两歧双歧杆菌细菌菌株、其组合物和相关应用
CN114127258B (zh) * 2019-07-08 2024-03-19 索法尔公司 两歧双歧杆菌细菌菌株、其组合物和相关应用
CN111110704A (zh) * 2020-02-14 2020-05-08 上海城建职业学院 一种益生菌菌剂、滴剂及其制备方法和应用
CN111110704B (zh) * 2020-02-14 2023-03-28 上海城建职业学院 一种益生菌菌剂、滴剂及其制备方法和应用
CN111743998A (zh) * 2020-06-04 2020-10-09 中通美雅生命健康(深圳)有限公司 用于辅助治疗肠炎组合物及其制备方法
CN113234619A (zh) * 2021-04-10 2021-08-10 江南大学 一株两歧双歧杆菌及其在缓解肠道损伤中的应用
CN116286439A (zh) * 2022-07-13 2023-06-23 四川大学 一株婴幼儿肠道来源的两歧双歧杆菌及应用
WO2024193633A1 (zh) * 2023-03-21 2024-09-26 四川厌氧生物科技有限责任公司 一种益生菌及其应用
JP2026505892A (ja) * 2023-03-21 2026-02-19 スーチュァン アナエロビック バイオテクノロジー カンパニー リミテッド プロバイオティクスおよびその使用
CN118879582A (zh) * 2024-09-19 2024-11-01 上海博诗康生物科技有限公司 一种细胞完整、分散均匀、稳定性强的后生元制备方法

Also Published As

Publication number Publication date
HRP20161792T1 (hr) 2017-03-10
NZ613544A (en) 2014-10-31
PL2481299T3 (pl) 2017-09-29
RU2013137404A (ru) 2015-03-10
DK2481299T3 (en) 2017-02-06
JP5956467B2 (ja) 2016-07-27
US9408879B2 (en) 2016-08-09
EP2481299A1 (en) 2012-08-01
EP2481299B1 (en) 2016-12-07
WO2012104226A1 (en) 2012-08-09
JP2014505065A (ja) 2014-02-27
CA2825980C (en) 2017-10-24
BR112013019258B1 (pt) 2021-09-08
PT2481299T (pt) 2017-03-08
ES2610908T3 (es) 2017-05-04
BR112013019258A2 (pt) 2016-10-11
HUE033189T2 (en) 2017-11-28
AU2012213576B2 (en) 2015-07-23
US20140056852A1 (en) 2014-02-27
CA2825980A1 (en) 2012-08-09
BR112013019258A8 (pt) 2017-09-19
RU2603285C2 (ru) 2016-11-27

Similar Documents

Publication Publication Date Title
AU2012213576B2 (en) Bifidobacterium bifidum strains for application in gastrointestinal diseases
AU2012213576A1 (en) Bifidobacterium bifidum strains for application in gastrointestinal diseases
JP4455333B2 (ja) プロバイオティック細菌：Ｌａｃｔｏｂａｃｉｌｌｕｓｆｅｒｍｅｎｔｕｍ
US20110165127A1 (en) Dairy-derived probiotic compositions and uses thereof
TWI594758B (zh) 包含雙歧桿菌的組合物、其製備方法及其用途
CN116570631A (zh) 微生物群落用于人类和动物健康的用途
CN112218646A (zh) 一种组合物及其应用
CN101998834B (zh) 用于缓解胃肠道病症相关症状的益生菌
CN117917475A (zh) 一种调节肠道菌群的植物乳植杆菌p16及其应用、产品和方法
KR20240118626A (ko) 락티플란티바실러스 플란타럼 y7 균주를 포함하는 장 기능 개선용 조성물
Baek et al. Probiotics and prebiotics as bioactive components in dairy products
Arora et al. Therapeutic potential of probiotics: A ray of hope or nightmare?
US20220193155A1 (en) Microbial compositions and methods for greater tolerability and prolonged shelf life
WO2019227414A1 (zh) 一种组合物及其应用
CN112236155A (zh) 一种组合物及其应用
Ozdal Overview of Probiotics from a Biotechnological Perspective
JP7663240B2 (ja) 腸管免疫賦活剤及びＩｇＡ産生促進剤
RU2735717C1 (ru) Штамм Bifidobacterium bifidum, используемый в качестве пробиотика
RU2771136C1 (ru) Штамм Meyerozyma (Pichia) guilliermondii (варианты), используемый для изготовления пре-, про- и аутопробиотических препаратов и продуктов для человека и животных, лечебно-профилактическое средство на его основе и способ его получения (варианты)
NZ613544B2 (en) Bifidobacterium bifidum strains for application in gastrointestinal diseases
Ringel What Are Probiotics and Do They Work in IBS?
RU2264452C2 (ru) Биопрепарат "бифистим от 3 до 12" для профилактики и лечения дисбактериозов и инфекционных болезней желудочно-кишечного тракта у детей в возрасте от 3 до 12 лет, биологически активная добавка к пище "бифистим от 3 до 12" для профилактики дисбактериозов и восстановления микрофлоры желудочно-кишечного тракта после антибиотикотерапии и других неблагоприятных воздействий у детей в возрасте от 3 до 12 лет и консорциум бифидобактерий для коррекции микрофлоры желудочно-кишечного тракта у детей в возрасте от 3 до 12 лет
EA043487B1 (ru) Штамм bifidobacterium bifidum 8, используемый в качестве пробиотика
Varshney et al. AJMR
Baek et al. Bioactive Components in Dairy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20150925

Address after: German Grey Foer Finn

Applicant after: Dr. Fisher Health Products Co., Ltd.

Address before: German Grey Foer Finn

Applicant before: Naturwohl Pharma GmbH

TA01 Transfer of patent application right

Effective date of registration: 20170401

Address after: German Grey Phil Finger

Applicant after: Sin F Mulas limited liability company

Address before: German Grey Foer Finn

Applicant before: Dr. Fisher Health Products Co., Ltd.

TA01 Transfer of patent application right
RJ01 Rejection of invention patent application after publication

Application publication date: 20131225

RJ01 Rejection of invention patent application after publication